Materials and information on the MitogenDx website are expressly deemed to be for general information purposes only and do not constitute medical or professional advice.
Type 1 diabetes (T1D), once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin. Insulin is a hormone needed to allow sugar (glucose) to enter cells to produce energy. T1D is considered an autoimmune disease and hence autoantibody tests are occasionally used to help confirm the diagnosis and also determine some complications and side effects for the disease.
The detection of autoantibodies against anti‐Glutamate Decarboxylase (GAD) is found in 70%-90% of patients with type 1 diabetes mellitus. The presence of anti-GAD antibodies gives a high predictive value for the patient to develop type 1 diabetes.
Patients with type 2 diabetes mellitus (T2DM) have significantly lower blood uromodulin concentrations than non-diabetics. Hence; below normal ranges of uromodulin can alert the clinician to possible emerging T2DM or other kidney diseases. Decreased uromodulin levels is possibly a sign of kidney function reduction.